These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Does the growth rate of a radionuclide-induced osteosarcoma depend on the skeletal dose rate during the growth period? Lloyd RD. Health Phys; 1990 Jan; 58(1):73-6. PubMed ID: 2294077 [No Abstract] [Full Text] [Related]
13. Postirradiation osteosarcoma of pelvic bone with unusual histological pattern. Permanetter W, Meister P, Füllner R. Pathol Res Pract; 1980 Dec; 170(1-3):243-51. PubMed ID: 18788167 [Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases. Bacci G, Longhi A, Forni C, Fabbri N, Briccoli A, Barbieri E, Mercuri M, Balladelli A, Ferrari S, Picci P. Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):505-11. PubMed ID: 17118571 [Abstract] [Full Text] [Related]
20. Epidemiology of bone tumors in Mexico City: retrospective clinicopathologic study of 566 patients at a referral institution. Baena-Ocampo Ldel C, Ramirez-Perez E, Linares-Gonzalez LM, Delgado-Chavez R. Ann Diagn Pathol; 2009 Feb 01; 13(1):16-21. PubMed ID: 19118777 [Abstract] [Full Text] [Related] Page: [Next] [New Search]